Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response

被引：0
|
作者：
John C Lam
Ranjani Somayaji
Michael G Surette
Harvey R Rabin
Michael D Parkins
机构：
[1] The University of Calgary,Department of Medicine
[2] McMaster University,The Department of Microbiology, Immunology and Infectious Disease
[3] The University of Calgary,undefined
来源：
BMC Infectious Diseases | / 15卷
关键词：
Treatment; Biomarker; Failure; Outcome; Bronchiectasis; Cefepime; Heterogeneity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Changes to colonising genotypes of pseudomonas aeruginosa with treatment of acute exacerbation of cystic fibrosis
    Pearce, DM
    Foweraker, JE
    Laughton, CR
    Haworth, CF
    Bilton, D
    THORAX, 2003, 58 : 63 - 63
  • [32] Total Cyanide in the Sputum of Cystic Fibrosis Patients During an Acute Exacerbation
    Guck, D.
    Tubbs, N.
    Kim, D.
    Haouzi, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa
    Parkins, Michael D.
    Rendall, Jacqueline C.
    Elborn, J. Stuart
    CHEST, 2012, 141 (02) : 485 - 493
  • [34] Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis
    Laguna, Theresa A.
    Williams, Cynthia B.
    Brandy, Kyle R.
    Welchlin-Bradford, Cole
    Moen, Catherine E.
    Reilly, Cavan S.
    Wendt, Christine H.
    JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (03) : 334 - 340
  • [35] Aminoglycoside dosing and monitoring for Pseudomonas aeruginosa during acute pulmonary exacerbations in cystic fibrosis
    Ochs, Madeleine A.
    Dillman, Nicholas O.
    Caverly, Lindsay J.
    Chaffee, Valerie D.
    PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 3634 - 3643
  • [36] INCIDENCE & RISK FACTORS FOR PULMONARY EXACERBATION TREATMENT FAILURE IN CYSTIC FIBROSIS PATIENTS CHRONICALLY INFECTED WITH PSEUDOMONAS AERUGINOSA
    Parkins, M. D.
    Ibrahim, M. A.
    Rendall, J. C.
    Elborn, J. S.
    PEDIATRIC PULMONOLOGY, 2010, : 327 - 327
  • [37] Iron Homeostasis during Cystic Fibrosis Pulmonary Exacerbation
    Gifford, Alex H.
    Moulton, Lisa A.
    Dorman, Dana B.
    Olbina, Gordana
    Westerman, Mark
    Parker, H. Worth
    Stanton, Bruce A.
    O'Toole, George A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2012, 5 (04): : 368 - 373
  • [38] Evaluation of Copeptin during Pulmonary Exacerbation in Cystic Fibrosis
    Wojsyk-Banaszak, I
    Sobkowiak, P.
    Jonczyk-Potoczna, K.
    Narozna, B.
    Langwinski, W.
    Szczepanik, M.
    Kycler, Z.
    Breborowicz, A.
    Szczepankiewicz, A.
    MEDIATORS OF INFLAMMATION, 2019, 2019
  • [39] Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes
    Nguyen, Dao
    Emond, Mary J.
    Mayer-Hamblett, Nicole
    Saiman, Lisa
    Marshall, Bruce C.
    Burns, Jane L.
    PEDIATRIC PULMONOLOGY, 2007, 42 (06) : 533 - 541
  • [40] Direct sputum analysis of Pseudomonas aeruginosa macrorestriction fragment genotypes in patients with cystic fibrosis
    Breitenstein, S
    Walter, S
    Bosshammer, J
    Romling, U
    Tummler, B
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1997, 186 (2-3) : 93 - 99
12345